156 related articles for article (PubMed ID: 7603742)
21. [Utility of morphometry and nucleolar organizer regions count in the differentiation of reactive and malignant mesothelial cells in pleural effusions].
Colecchia M; Agnelli T; Caronni E; Leopardi O
Pathologica; 1991; 83(1083):89-97. PubMed ID: 1866205
[TBL] [Abstract][Full Text] [Related]
22. Proliferative activity in the malignant cellular blue nevus.
Pich A; Chiusa L; Margaria E; Aloi F
Hum Pathol; 1993 Dec; 24(12):1323-9. PubMed ID: 7903955
[TBL] [Abstract][Full Text] [Related]
23. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
24. Manual and automated AgNOR count in differentiating reactive mesothelial from metastatic malignant cells in serous effusions.
Mohanty SK; Dey P; Rana P
Anal Quant Cytol Histol; 2003 Oct; 25(5):273-6. PubMed ID: 14603724
[TBL] [Abstract][Full Text] [Related]
25. Nucleolar organizer regions in human esophageal disorders: comparison with proliferating cell nuclear antigen by immunostaining.
Miyazaki S; Sasano H; Suzuki T; Sawai T; Nishihira T; Mori S
Mod Pathol; 1992 Jul; 5(4):396-401. PubMed ID: 1353881
[TBL] [Abstract][Full Text] [Related]
26. The value of PCNA and AgNOR staining in endoscopic biopsies of gastric mucosa.
Irazusta SP; Vassallo J; Magna LA; Metze K; Trevisan M
Pathol Res Pract; 1998; 194(1):33-9. PubMed ID: 9542745
[TBL] [Abstract][Full Text] [Related]
27. The AgNOR technique, PCNA immunohistochemistry, and DNA ploidy in the evaluation of choroid plexus biopsy specimens.
Centeno BA; Louis DN; Kupsky WJ; Preffer FI; Sobel RA
Am J Clin Pathol; 1993 Dec; 100(6):690-6. PubMed ID: 7902669
[TBL] [Abstract][Full Text] [Related]
28. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
29. Morphometric determination of AgNORs in breast carcinoma. Correlation with flow cytometry and proliferating cell nuclear antigen.
Bellotti M; Elsner B; Kahn A; Bezodnick L; Pisilli L; Greco P
Anal Quant Cytol Histol; 1997 Apr; 19(2):139-44. PubMed ID: 9113306
[TBL] [Abstract][Full Text] [Related]
30. Correlation between PCNA expression and AgNOR dots in pituitary adenomas.
Klencki M; Kurnatowska I; Słowińska-Klencka D; Lewiński A; Pawlikowski M
Endocr Pathol; 2001; 12(2):163-9. PubMed ID: 11579682
[TBL] [Abstract][Full Text] [Related]
31. The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation.
Soosay GN; Griffiths M; Papadaki L; Happerfield L; Bobrow L
J Pathol; 1991 Apr; 163(4):299-305. PubMed ID: 2033489
[TBL] [Abstract][Full Text] [Related]
32. Correlation between PCNA and AgNOR scores in non-Hodgkin's lymphomas using sequential staining technique.
Smith FG; Murray PG; Crocker J
J Clin Pathol; 1993 Jan; 46(1):28-31. PubMed ID: 8094401
[TBL] [Abstract][Full Text] [Related]
33. PCNA/AgNOR and Ki-67/AgNOR double staining in oral squamous cell carcinoma.
Costa Ade L; de Araújo NS; Pinto Ddos S; de Araújo VC
J Oral Pathol Med; 1999 Nov; 28(10):438-41. PubMed ID: 10551740
[TBL] [Abstract][Full Text] [Related]
34. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
[TBL] [Abstract][Full Text] [Related]
35. Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF.
Sakr WA; Sarkar FH; Sreepathi P; Drozdowicz S; Crissman JD
Prostate; 1993; 22(2):147-54. PubMed ID: 7681206
[TBL] [Abstract][Full Text] [Related]
36. The expression of proliferating cell nuclear antigen (PCNA) and of nucleolar organizer regions (AgNORs) correlates with the morphological type of bone marrow plasma cells in multiple myeloma (MM).
Usnarska-Zubkiewicz L; Maryniak R; Podolak-Dawidziak M; Woźniak Z; Jeleń M; Ramlau R; Poreba M; Kuliczkowski K
Pol Arch Med Wewn; 2003 Mar; 109(3):257-63. PubMed ID: 12924172
[TBL] [Abstract][Full Text] [Related]
37. Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas.
Mikou P; Kanavaros P; Aninos D; Tzardi M; Karameris A; Gorgoulis B; Papadopoulos N; Lavergne A; Galian A
Pathol Res Pract; 1993 Nov; 189(9):1004-9. PubMed ID: 7905623
[TBL] [Abstract][Full Text] [Related]
38. p120 and AgNOR nucleolar protein expression: a comparison with nuclear proliferation markers in oral pathology.
Migaldi M; Criscuolo M; Zunarelli E; Lo Bianco L; Martinelli AM; Barbolini G
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Feb; 85(2):189-96. PubMed ID: 9503455
[TBL] [Abstract][Full Text] [Related]
39. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
Delahunt B; Bethwaite PB; Thornton A; Ribas JL
Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
[TBL] [Abstract][Full Text] [Related]
40. [The study of PCNA expression and AgNORs counting adult-onset laryngeal papilloma].
Wang T; Wang D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Aug; 12(8):349-52. PubMed ID: 11263155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]